6th Dec 2006 17:37
Hikma Pharmaceuticals Plc06 December 2006 Update on Non-Executive Director's Appointments LONDON, 6 December 2006 - Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK), themultinational pharmaceuticals group, announces that Michael Ashton, anon-executive Director and Chairman of the Remuneration Committee, has beenappointed as the Chief Executive Officer of LMA International NV, a Singaporelisted company. - ENDS -Enquiries: Hikma Pharmaceuticals PLCSusan Ringdal +44 20 7399 2760Investor Relations Director Brunswick GroupJon Coles / Justine McIlroy / Alex Tweed +44 20 7404 5959 About HikmaHikma Pharmaceuticals PLC is a multinational pharmaceutical group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: Generic, Branded and InjectablePharmaceuticals. Hikma's operations are based principally in the United States,the Middle East and North Africa ("MENA") region and Europe. In 2005, the Grouphad revenue of $262 million and profit attributable to shareholders of $44million. At 31 December 2005, the Group had over 1,800 employees. For news andother information, please visit www.hikma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hikma Pharmaceuticals